Improving public health through action-oriented information

Our mission is to provide timely and high-quality information needed for decision-making, planning and evaluating vaccine and prescription drug programs by:

  • conducting collaborative interdisciplinary research on uptake, safety and effectiveness of the vaccines and drugs used in Manitoba;

  • carrying out mathematical modeling and cost-effectiveness studies;

  • conducting disease burden and trend studies necessary for planning the introduction of new vaccines; and

  • performing ad hoc investigations of vaccine and drug adverse events.

The Centre at a glance

  • 12 scientists, programmers and research associates
  • 6 trainees
  • Over 50 ongoing projects
  • $7.0 million in external funding (>$48 million in collaborative projects)
  • 113 peer-reviewed publications
  • More than 150 peer-reviewed abstracts and presentations

In the Media

Sep. 5, 2019

Press Release: Uniting Diverse Groups to Improve Adult Influenza Vaccination in Canada

May. 8, 2019

More than a third of all cancers affecting Canadians can be prevented by a combination of sound policymaking and health education

Sep. 12, 2017

Duo inducted into Royal Society of Canada’s college

May. 28, 2015

Cancer stats sound alarm bell

Feb. 3, 2015

Preventing cancer: Research into the use of common medicines might help

Oct. 24, 2014

Winnipeg data a factor in developing vaccine

Mar. 28, 2014

Study: Mutations during egg step cut last year's flu vaccine effectiveness

Mar. 27, 2014

Mutations explain poor showing of 2012 flu vaccine

Mar. 25, 2014

Flu vaccine offered only modest protection in 2012-13: study

Jan. 13, 2014

Quadrivalent Human Papillomavirus Vaccine Provides Poorer Protection in Women 18 and Older or with Abnormal Cytology

Jan. 6, 2014

HPV Vaccine: The Earlier, the Better

Jul. 1, 2013

Old drugs, new treatments

Latest Posts

Sep. 4, 2019

Posts